Logo image of BLSH

BULLISH (BLSH) Stock Fundamental Analysis

NYSE:BLSH - KYG169101204 - Common Stock

52.3098 USD
+3.3 (+6.73%)
Last: 9/5/2025, 3:54:09 PM
Fundamental Rating

3

BLSH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 239 industry peers in the Capital Markets industry. While BLSH seems to be doing ok healthwise, there are quite some concerns on its profitability. BLSH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

BLSH had positive earnings in the past year.
In the past year BLSH had a positive cash flow from operations.
In multiple years BLSH reported negative net income over the last 5 years.
In the past 5 years BLSH reported 4 times negative operating cash flow.
BLSH Yearly Net Income VS EBIT VS OCF VS FCFBLSH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

1.2 Ratios

The Return On Assets of BLSH (2.95%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 4.01%, BLSH is doing worse than 64.44% of the companies in the same industry.
Industry RankSector Rank
ROA 2.95%
ROE 4.01%
ROIC N/A
ROA(3y)-16.69%
ROA(5y)-13.85%
ROE(3y)-40.28%
ROE(5y)-28.85%
ROIC(3y)N/A
ROIC(5y)N/A
BLSH Yearly ROA, ROE, ROICBLSH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

BLSH has a Profit Margin of 0.03%. This is in the lower half of the industry: BLSH underperforms 72.80% of its industry peers.
BLSH has a Gross Margin of 0.04%. This is in the lower half of the industry: BLSH underperforms 71.97% of its industry peers.
Industry RankSector Rank
OM N/A
PM (TTM) 0.03%
GM 0.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BLSH Yearly Profit, Operating, Gross MarginsBLSH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

6

2. Health

2.1 Basic Checks

Compared to 1 year ago, BLSH has about the same amount of shares outstanding.
BLSH has a better debt/assets ratio than last year.
BLSH Yearly Shares OutstandingBLSH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M
BLSH Yearly Total Debt VS Total AssetsBLSH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

BLSH has an Altman-Z score of 100.08. This indicates that BLSH is financially healthy and has little risk of bankruptcy at the moment.
BLSH has a Altman-Z score of 100.08. This is amongst the best in the industry. BLSH outperforms 100.00% of its industry peers.
BLSH has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
BLSH's Debt to Equity ratio of 0.28 is fine compared to the rest of the industry. BLSH outperforms 74.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Altman-Z 100.08
ROIC/WACCN/A
WACCN/A
BLSH Yearly LT Debt VS Equity VS FCFBLSH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 15.98 indicates that BLSH has no problem at all paying its short term obligations.
BLSH has a better Current ratio (15.98) than 97.49% of its industry peers.
A Quick Ratio of 14.76 indicates that BLSH has no problem at all paying its short term obligations.
BLSH has a better Quick ratio (14.76) than 96.65% of its industry peers.
Industry RankSector Rank
Current Ratio 15.98
Quick Ratio 14.76
BLSH Yearly Current Assets VS Current LiabilitesBLSH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

The earnings per share for BLSH have decreased strongly by -93.92% in the last year.
The Revenue has grown by 114.78% in the past year. This is a very strong growth!
Measured over the past years, BLSH shows a very strong growth in Revenue. The Revenue has been growing by 474.20% on average per year.
EPS 1Y (TTM)-93.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-430%
Revenue 1Y (TTM)114.78%
Revenue growth 3Y474.21%
Revenue growth 5YN/A
Sales Q2Q%-0.21%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BLSH Yearly Revenue VS EstimatesBLSH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 50B 100B 150B 200B 250B

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 98.70, BLSH can be considered very expensive at the moment.
Based on the Price/Earnings ratio, BLSH is valued a bit more expensive than the industry average as 78.24% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 27.03. BLSH is valued rather expensively when compared to this.
Industry RankSector Rank
PE 98.7
Fwd PE N/A
BLSH Price Earnings VS Forward Price EarningsBLSH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLSH Per share dataBLSH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BLSH!.
Industry RankSector Rank
Dividend Yield N/A

BULLISH

NYSE:BLSH (9/5/2025, 3:54:09 PM)

52.3098

+3.3 (+6.73%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.79B
AnalystsN/A
Price TargetN/A
Short Float %6.09%
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 98.7
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF 200.89
P/B 3.98
P/tB 4.18
EV/EBITDA N/A
EPS(TTM)0.53
EY1.01%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)0.26
OCFY0.5%
SpS1680.11
BVpS13.15
TBVpS12.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.95%
ROE 4.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.03%
GM 0.04%
FCFM N/A
ROA(3y)-16.69%
ROA(5y)-13.85%
ROE(3y)-40.28%
ROE(5y)-28.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover93.89
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 663.45%
Cap/Sales 0.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 15.98
Quick Ratio 14.76
Altman-Z 100.08
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)79.12%
Cap/Depr(5y)N/A
Cap/Sales(3y)0%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-93.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-430%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)114.78%
Revenue growth 3Y474.21%
Revenue growth 5YN/A
Sales Q2Q%-0.21%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-38.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y64.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.33%
OCF growth 3YN/A
OCF growth 5YN/A